MNS
About MNS
MNS is a medtech firm developing Miracus, needle-free patch platform designed to replace injections with self-administered drug delivery.
Company Facts
- Funding stage: Seed
- Last round: Seed (Nov 2025)
Canonical: https://fsome.com/organization/mns-17205141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.